Bookmark list

Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions

27-May-2011 - Germany

Evotec AG announced that it has entered into a strategic alliance with PsychoGenics Inc. to provide integrated CNS drug discovery solutions to pharmaceutical and biotech companies. The two companies will work together in a seamless fashion to provide existing and new clients access to their complementary drug discovery platforms for the identification and development of new therapeutics to treat CNS disorders.

Dr Mario Polywka, Chief Operating Officer at Evotec stated: "By bringing together the industry leading CNS drug discovery platforms of Evotec and PsychoGenics, our clients and partners will benefit through an increased probability of success and faster and more informed decision making in their drug discovery efforts with the goal of delivering pre-clinical candidates in the most time and cost efficient manner."

Dr Emer Leahy, President and CEO of PsychoGenics explained: "We are delighted to enter into this collaboration with Evotec, an innovative leader in drug discovery. PsychoGenics and Evotec each have a long-standing history of successful partnerships in which they share discovery risk with pharmaceutical companies, and have delivered several pre-clinical candidates. Now, by combining forces, partners have the opportunity to avail themselves of fully-integrated and proprietary capabilities to drive and transform their CNS discovery programs and lower their overall risk."

No financial details are disclosed.

https://www.bionity.com/en/news/132686/evotec-and-psychogenics-enter-into-a-strategic-alliance-to-provide-integrated-cns-drug-discovery-solutions.html

Machine-learning driven findings uncover new cellular players in tumor microenvironment

Involvement of adipocytes in nivolumab response in ipilimumab resistant melanoma patients

Get the life science industry in your inbox

Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions

Machine-learning driven findings uncover new cellular players in tumor microenvironment

Other news from the department business & finance

Infrareal takes over pharmaceutical and biotech site in Orth, Lower Austria from Takeda

KNAUER now officially a place of the future

Better standard for laboratory analysis

Medtech start-up is developing a novel obesity therapy

Side-effect free RNA therapeutics active only in diseased cells

Merck accelerates growth, driven by all business sectors

Mainz Biomed and Thermo Fisher Scientific sign collaboration agreement

mediaire transforms radiology with AI

Click & Try: A Failed Experiment and Chance Opened up new Paths to an Established Reaction for Chemists

Turning waste into microbial gold for a sustainable future

Bayer: Strategic progress in challenging business environment

Collaboration between medac and start-up chiron to develop organ-on-chip technology

Cyber Valley unites AI & robotics expertise for the healthcare sector

What influences the success of founders

BASF partners with Acies Bio to drive sustainable production of Personal and Home Care ingredients

Tosoh Bioscience – Separation & Purification Expands European Headquarters in Griesheim, Germany

Evotec announces sale of API manufacturing facility to Monacum Partners

Aignostics secures $34 million Series B to improve precision medicine with AI

Successful closing: Syntegon and Telstar officially join forces

Berlin-Based Neurotech Startup Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease

Get the life science industry in your inbox

Most read news

Berlin-Based Neurotech Startup Secures Investment for the Development of a Digital Drug to Treat Alzheimer’s Disease

Microbe of the Year 2023: Bacillus subtilis – for health and technology

Superspreader fibrils caught in the act

The preparation makes the poison

A “chemical ChatGPT” for new medications

Protein interactions: who is partying with whom and who is ruining the party?

Possible approach for the treatment of neurological and neuropsychiatric diseases discovered

Is the physics of red blood cells in bats a key to "artificial hibernation" for humans?

Understanding How Mutations Affect Diseases

Ovulation filmed from start to finish for the first time

Diabetes switch in DNA

Bayer partners with innovative hormone monitoring device start-up

More news from our other portals

Flower Power: Lavender Oil Fuels Batteries for the Future

Energy drinks - the underestimated danger

AI-driven mobile robots team up to tackle chemical synthesis

The fireproof battery

Precise and fast kokumi effect

Researcher finds gold - and other metals

Hydrogen: Breakthrough in alkaline membrane electrolyzers

Solein® tops the list of NASA’s alternatives for space food systems

Machine learning can predict the mechanical properties of polymers

When it comes to building muscle, not all proteins are created equal

Hazardous chemicals found in cosmetics

Mintel announces Global Food and Drink Trends for 2025

New technology for solid state batteries

1.3 million pizzas with solar power

Inspired by nature: biophysicist develops innovative microplastic filters

Full-bodied cheese flavor–prediction of flavor development soon possible thanks to new method

New Fast and Sustainable Method for Hydrogen Production

With “electro-agriculture,” plants can produce food in the dark and with 94% less land, bioengineers say

Porsche may acquire stake in Varta and majority stake in e-mobility division "V4Drive"

Sustainable food innovations from broccoli side streams

Life of zinc batteries drastically extended

Making scents of aromas that differentiate beer and wine

So close that even molecules turn red...

So close that even
molecules turn red...